Independent pharmacy
Financing for independent pharmacies
Direct answer
Practition Finance explains how independent pharmacies finance an acquisition of the business or its prescription files, an inventory line, and owner-occupied real estate. The site maps practice acquisition, a line of credit, commercial real estate, and SBA 7(a) and 504 financing to script count and pharmacy benefit manager contract terms.
As of October 2026
An independent pharmacy's value sits largely in its script files and the payer mix behind them, and a buyer acquiring a pharmacy is really acquiring a stream of refills tied to specific pharmacy benefit manager contracts. Script count and file retention after a change of ownership are the numbers a lender wants before it looks at anything else on the acquisition file.
The daily cash mechanics run on a gap most pharmacies live with permanently: wholesaler terms typically require payment on a 14 to 45 day cycle, while payer reimbursement, especially after direct and indirect remuneration fees are assessed, can lag well behind that. An inventory line bridging that gap is a standing capital need, not a one-time event.
Owner-occupied real estate rounds out the profile for pharmacies that hold their own building. That real estate decision interacts with the pharmacy's PBM contract terms, because a pharmacy locked into unfavorable reimbursement has less room to support a real estate debt payment on top of operating expenses.
The 3 capital events you will face
Acquisition of the business or the prescription files
A pharmacy acquisition can be structured as a purchase of the entire business, including its lease and fixtures, or as a purchase of the prescription files alone, transferring the patient relationships and payer credentialing to the buyer's existing or new location. File retention after the transfer is the key underwriting question, since a share of patients do not follow a file transfer to a new pharmacy, and a lender wants to see historical retention rates on comparable transactions before sizing the loan against projected script volume. Gross margin after direct and indirect remuneration fees, not gross script revenue, is what the acquisition debt service is measured against.
Inventory line bridging wholesale terms and reimbursement
A pharmacy pays its wholesaler on a 14 to 45 day cycle while it waits for payer reimbursement that can run longer once claims adjudication and DIR fee assessments are factored in, and DIR fees are often assessed weeks or months after the sale, which retroactively reduces margin the pharmacy already booked. An inventory or working capital line sized to bridge that timing gap is close to a permanent feature of independent pharmacy operations rather than a response to a single bad stretch. Lenders normalize DIR fees out of historical profit when sizing this facility, since the fee timing distorts trailing financials.
Owner-occupied real estate
A pharmacy that owns its building finances that real estate on a track separate from the operating business, and SBA 504 is a common structure for owner-occupied pharmacy real estate given its pricing and equity injection terms. The real estate decision is not independent of the pharmacy's PBM contract terms, though, because a pharmacy facing reimbursement below acquisition cost on key drug categories has less operating margin available to support a real estate debt payment, and a lender reviews both files together even when they are financed separately.
Programs ranked for your situation
Independent pharmacies rely on a compact set of programs, ranked by how the acquisition, inventory, and real estate needs in this niche typically arise
- 01Practice acquisition
Financing for buying an existing pharmacy or its prescription files, underwritten on script count, file retention history, and margin after PBM fees
- 02Business line of credit
The standing facility that bridges wholesaler payment terms against payer reimbursement timing, a near-permanent need in this niche
- 03Commercial real estate, owner-occupied
Financing for a pharmacy's owner-occupied building when it is not structured through SBA 504
- 04SBA 7(a) and 504
7(a) commonly finances the acquisition and inventory needs; 504 is favored for owner-occupied pharmacy real estate
What a funder reads on your file first
A lender underwriting an independent pharmacy reads the script count and the PBM contract file before the P&L
| What is read | Market reference | Confidence | How it is read |
|---|---|---|---|
| Script count and file retention | Read on the file | Prescription volume and, on an acquisition, the share of patient files that historically transfer and stay with the new owner. | |
| Gross margin after direct and indirect remuneration | Read on the file | Margin measured net of DIR fees, which are often assessed after the sale and distort trailing profit if not normalized out. | |
| Wholesaler terms against reimbursement timing | Read on the file | The gap between the 14 to 45 day wholesaler payment cycle and the pace of payer reimbursement, which sizes the inventory or working capital line. | |
| Payer mix and contract exposure | Read on the file | The pharmacy's concentration across PBM contracts and government payers, and how much of its margin depends on a small number of reimbursement agreements. | |
| Days in accounts receivable | Under 30 high performing, 30 to 40 acceptable, over 50 a problem | VerifiedAugust 2026 | How quickly third-party claims convert to cash, a secondary signal behind script count and margin. |
PBM contracts set terms a buyer inherits, not negotiates
Pharmacy benefit manager contracts set the reimbursement a buyer inherits, and they are not negotiable at closing. An acquiring pharmacist typically steps into the seller's existing PBM agreements rather than negotiating new terms, which means the acquisition's actual margin profile is set well before the buyer takes over operations.
Direct and indirect remuneration fees add a layer of uncertainty on top of that inherited reimbursement, since PBMs frequently assess DIR fees retroactively, weeks or months after a prescription is filled and paid. A pharmacy's trailing financials can overstate margin until those fees are normalized out.
Below-acquisition-cost reimbursement on certain drug categories is a known pressure point in this niche, and lenders reviewing an independent pharmacy file weigh how much of the pharmacy's dispensing volume sits in categories where reimbursement does not reliably cover the pharmacy's own cost.
Key facts
The figures behind an independent pharmacy acquisition or real estate financing decision
- Days in AR benchmark: Under 30 high performing, 30 to 40 acceptable, over 50 a problem5VerifiedAugust 2026
- SBA 504 debenture rate: About 6.2% on the 20-year and 6.17% on the 25-year, July 20266VerifiedJuly 2026
- 504 equity injection: 10% established, 15% startup or special-use7VerifiedAugust 2026
- SBA 7(a) maximum: $5,000,000, guaranty 85% to $150,000 and 75% above8VerifiedAugust 2026
These are figures the market publishes, current as of the date beside each one. None of it is a quote, an offer, or an indication of terms.
Your options, program by program
- SBA 7(a) and 504 for independent pharmacy
SBA 7(a) and 504 financing for independent pharmacy acquisitions, script file purchases, and owner-occupied real estate against PBM reimbursement terms.
- Acquisition financing for independent pharmacy
Buying an independent pharmacy or its script files. How lenders weigh PBM contracts, payer mix, and gross margin after DIR fees on an acquisition.
Other fields in the same language
Operators read on the same numbers, each with its own capital events and document set
What owners in this field ask
01What does a lender look at first when financing a pharmacy acquisition?
A lender typically starts with script count and, on an acquisition, historical file retention rates, since not every patient file transfers to a new owner. Gross margin after direct and indirect remuneration fees follows, because trailing revenue alone overstates the margin a buyer will actually see.
02Why does an independent pharmacy need a standing line of credit?
A pharmacy typically pays its wholesaler on a 14 to 45 day cycle while payer reimbursement, including direct and indirect remuneration fee assessments, can lag behind that. A line of credit sized to that timing gap is close to a permanent operating need rather than a response to a single event.
03What are direct and indirect remuneration fees and why do they matter for financing?
DIR fees are amounts a pharmacy benefit manager assesses against a pharmacy, often weeks or months after a prescription was filled and paid. Because the fee lands after the fact, it can retroactively reduce margin the pharmacy already recorded, so lenders normalize DIR fees out of historical profit when underwriting.
04Can a buyer renegotiate PBM contract terms after acquiring a pharmacy?
Generally no at the point of closing. A buyer typically steps into the seller's existing pharmacy benefit manager agreements, so the reimbursement terms behind the acquisition are effectively fixed before the new owner takes over, which is why lenders review those contracts closely before financing the deal.
05Is owner-occupied pharmacy real estate financed differently than the pharmacy business itself?
Often yes. Owner-occupied real estate is commonly financed through an SBA 504 structure given its pricing and equity injection terms, while the pharmacy's acquisition and inventory needs run through a separate facility such as SBA 7(a) or a line of credit.
06How does reimbursement below acquisition cost affect a pharmacy's financing?
When a meaningful share of a pharmacy's dispensing volume sits in drug categories reimbursed below what the pharmacy itself pays to acquire the drug, that volume pressures overall margin. Lenders weigh how concentrated a pharmacy's business is in those categories when assessing debt service capacity.
Sources
Take the checklist with you
Healthcare businesses
Healthcare Cash Flow Kit
The gap between service date and remittance, and what closes it
PDF · 9 pages · v1.0
- The healthcare business document checklist, in the order a funder asks for it
- The factoring readiness checklist
- The double lockbox explained, with the government-payer rule
- The payroll gap worksheet
- Net collectible value versus gross charges, worked through
- The revenue-cycle benchmarks a funder checks first
Practition Finance can map an independent pharmacy's script files, PBM contracts, and wholesaler terms to an acquisition, inventory, or real estate structure and refer the pharmacy to funding partners
See which programs fit you
The Fit Check is educational. It names the program categories commonly used in situations like the one described, and it recommends nothing.